Japan to donate 300,000 AstraZeneca doses to Thailand

Japan to donate 300,000 AstraZeneca doses to Thailand

Vials labelled
Vials labelled "Astra Zeneca COVID-19 Coronavirus Vaccine" and a syringe are seen in front of a displayed Japan flag, in this illustration photo taken March 14, 2021. (Reuters file photo)

Japan said on Tuesday it will donate an additional 1.3 million AstraZeneca Covid-19 vaccine doses to Taiwan and other Asian neighbours, including 300,000 doses to Thailand.

Taiwan will get 500,000 more doses, bringing Japan's total donation to the island to 3.9 million.

The latest donation batch will go out as soon as possible, and includes another 400,000 shots for Vietnam, 300,000 for Thailand, and 100,000 to Brunei.

To date, Japan has given out more than 23 million doses of the AstraZeneca vaccine produced in Japan to countries in South Asia and the Pacific islands.

Japan has fully vaccinated 50% of its population, according to government data on Monday. The country has relied mainly on imported mRNA-type vaccines from Pfizer Inc and Moderna Inc for its domestic inoculation push, choosing to give away most of its supplies of the AstraZeneca shot.

Learn from listening

Click play to listen to audio for this story, or download to save the file
: :

Vocabulary

  • batch: a group of things considered similar in type - พวก, ชุด, กลุ่ม
  • domestic: inside the country being talked about - ภายในประเทศ
  • donate: to give something such as money or goods to an organisation, especially to a temple, charity, school, political party, etc. - บริจาค
  • donation: money or goods that you give to an organisation, especially one that helps people - เงินหรือสิ่งของบริจาค
  • inoculation (noun): an act of protecting a person or an animal from catching a particular disease by injecting them with a mild form of the disease - การฉีดวัคซีน,
  • population: a particular group of people or animals living in a particular area - กลุ่มที่อาศัยอยู่ในที่เดียวกัน
  • rely on: to depend on or trust - พึ่งพา  เชื่อถือ ไว้ใจ
Do you like the content of this article?
COMMENT